Analyst David Risinger of Leerink Partners reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), retaining the price target of $970.00. Don't Miss our Black Friday Offers: David Risinger ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...

The new mens range debuted at a VIP fashion show in Palm Beach last week, and will arrive in stores in February for the ...

For anyone who’s only ever thought of Burberry and Gucci as brands that were beautiful to look at, but too-high-end to touch, this Gilt flash sale will leave you pleasantly surprised! Horsebits and ...

This $100 getaway bag would be great for your next Disney trip, but with its highlighter pink palette and preppy print, it'll ...

Amazon is offering a major price drop on the Samsung Galaxy Buds FE that makes them cheaper than ever to snag before Black ...

If you’re looking to get yourself a Gucci belt, now is the perfect time. Gilt is currently hosting a major sale on Gucci, with up to 40% off some of the brand’s most popular styles ...

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster weight loss drug Zepbound was not dragging down sales. Pfizer sales ...

Eli Lilly (NYSE: LLY) and its investors this past week learned a hard lesson: The sky is no longer the limit when it comes to sales of its blockbuster glucagon-like peptide 1 (GLP-1) drugs for ...

Elevate your golf game with this Lilly Pulitzer matching set, featuring a UPF 50 jacket and skort in a fun pink gingham print for effortless style on the course. Add a touch of coastal charm to ...